Crossover Bioequivalence Study of Tinidazole 500 mg Tablets Under Fed Conditions

NCT01591889 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Trichomoniasis

Interventions

DRUG: Tinidazole
DRUG: Tinidazole

Sponsor

Roxane Laboratories